News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and viewsWhy is Wales falling behind the rest of the UK on mpMRI?
Our recent Freedom of Information request to the NHS showed access to the latest diagnostic scans before a biopsy was worse in Wales than the other home nations. Find out why, what we're doing about it and how you can help.
"My life was in the balance and so obviously I decided to pay for an mpMRI"
When Raymond Starr was diagnosed with prostate cancer last year, he was refused an mpMRI on the NHS because there are no scanners available in North Wales. He's now working with us to make sure the revolutionary diagnostic technique is available to all men in the UK.
NICE decision on abiraterone could take away best hope for some men with incurable disease
BLOG: Abiraterone should continue to be available on the NHS and opened up to all men with newly diagnosed advanced prostated cancer, argues our policy manager Tim Windle, as the UK’s drug guidelines body is set to rule on the future of the treatment.
How your support led to Theresa May’s £75 million research promise and why we can't stop now
BLOG: After Theresa May’s announcement of £75 million for prostate cancer research, Ian le Guillou looks at how government and charity funding work together and how your support is critical to bag the big bucks needed for major breakthroughs.
Theresa May joins mission to stop prostate cancer being a killer revealing £75m research fund
The Prime Minister is making the biggest prostate cancer funding announcement we have seen – a move we hope will make a significant contribution to our bid to stop prostate cancer taking lives.
Behind the headlines: Symptoms, screening and PSA – should I have a test?
This week the PSA test is in the media spotlight after results from a large prostate cancer trial were released. So what should men do if they are worried about prostate cancer? Who should have a PSA test? Our Specialist Nurse, Ali Rooke sets out the facts.
One-stop-shop pilot for diagnosing suspected prostate cancer scoops headlines
This weekend, national media picked up a story that we reported in November about an NHS England scheme trialling a “one-stop-shop” process for diagnosing prostate cancer. The story was picked up from The Daily Mail, who have recently begun a prostate cancer campaign after being moved by our news that prostate cancer is now the third biggest cancer killer.
Hormone therapy shortage should only last a few months says drugs industry body
After we investigated complaints from men unable to get hold of the off-patent prostate cancer drug, bicalutamide, the British Generic Manufacturers' Association has told us problems with supply shouldn't last long.
Behind the scenes of drug approvals: what we’re doing to get you access to the best possible treatments
BLOG: BLOG: When a successful clinical trial of a new treatment is reported, what happens next? Even the most exciting new methods still have a long way to go before doctors can prescribe them. Behind the scenes, we work to try and make sure these treatments get to the men who need them. This month, Policy Manager, Tim Windle, is in the thick of it in a bid to get a combination therapy for advanced disease approved.
New data shows men wait four times longer to be diagnosed with prostate cancer than women with breast cancer
Results of a report released today have shown that the average time it takes for a man to receive a diagnosis of prostate cancer in England is 56 days following referral – far longer than the 28 day target that health officials are working towards and the average 14 day diagnosis period for breast cancer. We look into the reasons behind this dramatic difference and what is being done about it.